Mydecine Innovations Group (TSE:MYCO)

Mydecine Innovations Group (MYCO) Income Statement


Mydecine Innovations Group Income Statement

Last quarter (Q2 2023), Mydecine Innovations Group's total revenue was C$―, a decrease of ― from the same quarter last year. In Q2, Mydecine Innovations Group's net income was C$-3.18M. See Mydecine Innovations Group’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
--C$ 7.49KC$ 2.62KC$ 125.57KC$ 207.66K
Cost of Revenue
----C$ 94.05KC$ 109.82K
Gross Profit
--C$ 7.49KC$ 2.62KC$ 31.52KC$ 97.83K
Operating Expense
C$ 15.24MC$ 16.39MC$ 22.69MC$ 11.46MC$ 3.43MC$ 5.90M
Operating Income
C$ -15.24MC$ -16.39MC$ -22.68MC$ -11.46MC$ -3.39MC$ -5.81M
Net Non Operating Interest Income Expense
C$ -678.95KC$ -664.07KC$ 205.27KC$ 182.87KC$ 80.52KC$ 63.11K
Other Income Expense
C$ 3.88MC$ 12.69KC$ -693.51KC$ -15.23MC$ -17.95MC$ -7.49M
Pretax Income
C$ -19.99MC$ -17.24MC$ -23.58MC$ -26.88MC$ -21.43MC$ -13.36M
Tax Provision
Earnings From Equity Interest Net Of Tax
---C$ 333.60K--
Net Income Common Stockholders
C$ -14.31MC$ -11.57MC$ -28.90MC$ -26.95MC$ -21.43MC$ -13.36M
Basic EPS
Diluted EPS
Basic Average Shares
Diluted Average Shares
Dividend Per Share
Total Operating Income As Reported
Reported Normalized Basic E P S
Reported Normalized Diluted E P S
Rent Expense Supplemental
Total Expenses
C$ 15.24MC$ 16.39MC$ -22.69MC$ -11.46MC$ -3.52MC$ -6.01M
Net Income From Continuing And Discontinued Operation
C$ -14.31MC$ -11.57MC$ -28.90MC$ -26.95MC$ -21.43MC$ -13.36M
Normalized Income
C$ -14.38MC$ -12.36MC$ -17.33MC$ -3.65MC$ 2.36MC$ -1.99M
Interest Expense
C$ -19.06MC$ -16.33MC$ -23.38MC$ -26.69MC$ -21.35MC$ -13.29M
C$ -19.02MC$ -16.20MC$ -23.14MC$ -26.64MC$ -21.30MC$ -13.26M
Currency in CAD

Mydecine Innovations Group Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis